Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
scPharmaceuticals Inc (SCPH)
NASDAQ:SCPH
scPharmaceuticals (SCPH) Stock Price & Analysis
206 Followers
SCPH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.68 - $10.38
Previous Close$6.85
Volume224.74K
Average Volume (3M)509.54K
Market Cap
$233.27M
Enterprise Value$198.67M
Total Cash (Recent Filing)$45.19M
Total Debt (Recent Filing)$10.59M
Price to Earnings (P/E)-5.4
Beta-0.14
Next Earnings
Mar 22, 2023EPS Estimate
-$0.39Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.27
Shares Outstanding34,054,083
10 Day Avg. Volume1,150,128
30 Day Avg. Volume509,540
Standard Deviation0.21
R-Squared0.00241
Alpha0.00688
Financial Highlights & Ratios
Price to Book (P/B)10.37
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-14.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-6.12
Forecast
1Y Price Target
$13.33Price Target Upside94.03% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
scPharmaceuticals News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SCPH FAQ
What was scPharmaceuticals Inc’s price range in the past 12 months?
scPharmaceuticals Inc lowest stock price was $3.68 and its highest was $10.38 in the past 12 months.
What is scPharmaceuticals Inc’s market cap?
Currently, no data Available
When is scPharmaceuticals Inc’s upcoming earnings report date?
scPharmaceuticals Inc’s upcoming earnings report date is Mar 22, 2023 which is tomorrow.
How were scPharmaceuticals Inc’s earnings last quarter?
scPharmaceuticals Inc released its earnings results on Nov 09, 2022. The company reported -$0.37 earnings per share for the quarter, beating the consensus estimate of -$0.382 by $0.012.
Is scPharmaceuticals Inc overvalued?
According to Wall Street analysts scPharmaceuticals Inc’s price is currently Undervalued.
Does scPharmaceuticals Inc pay dividends?
scPharmaceuticals Inc does not currently pay dividends.
What is scPharmaceuticals Inc’s EPS estimate?
scPharmaceuticals Inc’s EPS estimate is -$0.39.
How many shares outstanding does scPharmaceuticals Inc have?
scPharmaceuticals Inc has 34,054,085 shares outstanding.
What happened to scPharmaceuticals Inc’s price movement after its last earnings report?
scPharmaceuticals Inc reported an EPS of -$0.37 in its last earnings report, beating expectations of -$0.382. Following the earnings report the stock price went up 12.268%.
Which hedge fund is a major shareholder of scPharmaceuticals Inc?
Among the largest hedge funds holding scPharmaceuticals Inc’s share is RA Capital Management. It holds scPharmaceuticals Inc’s shares valued at 13M.
---
scPharmaceuticals Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$13.33 (94.03% Upside)
$13.33 (94.03% Upside)
Blogger Sentiment
Neutral
SCPH Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 2.8M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 2.4%
Last 30 Days ▲ 2.6%
Last 30 Days ▲ 2.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
31.47%
12-Months-Change
Fundamentals
Return on Equity
-74.10%
Trailing 12-Months
Asset Growth
-44.71%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
scPharmaceuticals Inc
scPharmaceuticals, Inc.engages in the development of transformative pharmaceutical products for subcutaneous delivery. Its products include furosemide, used as parenteral diuretic in treating heart failure and ceftriaxone, used as parenteral antibiotic outside the hospital setting. The company was founded by Pieter Muntendam and Bertram Pitt in February 2013 and is headquartered in Burlington, MA.
---
---